We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYH icon
751
Community Health Systems
CYH
$393M
– –
-70,392
Closed -$226K
CYTK icon
752
Cytokinetics
CYTK
$10.8B
– –
-3,765
Closed -$207K
DAWN
753
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-42,345
Closed -$299K
DDOG icon
754
Datadog
DDOG
$89.3B
– –
-1,930
Closed -$275K
DEC
755
Diversified Energy Company
DEC
$864M
– –
-13,213
Closed -$185K
DECK icon
756
Deckers Outdoor
DECK
$14.2B
– –
-2,182
Closed -$221K
DHI icon
757
D.R. Horton
DHI
$42.3B
– –
-1,244
Closed -$211K
DIOD icon
758
Diodes
DIOD
$3.69B
– –
-4,548
Closed -$242K
DNA icon
759
Ginkgo Bioworks
DNA
$503M
– –
-13,177
Closed -$192K
DNUT icon
760
Krispy Kreme
DNUT
$564M
– –
-16,096
Closed -$62.3K
DOCU
761
DocuSign
DOCU
$10.7B
– –
-2,851
Closed -$206K
DOMO icon
762
Domo
DOMO
$170M
– –
-23,127
Closed -$366K
DOV icon
763
Dover
DOV
$27.4B
– –
-1,435
Closed -$239K
DPZ icon
764
Domino's
DPZ
$11.6B
– –
-966
Closed -$417K
DSGR icon
765
Distribution Solutions Group
DSGR
$1.6B
– –
-8,323
Closed -$250K
DV icon
766
DoubleVerify
DV
$1.73B
– –
-32,733
Closed -$392K
DX
767
Dynex Capital
DX
$3.07B
– –
-10,400
Closed -$128K
EARN
768
Ellington Residential Mortgage REIT
EARN
$167M
– –
-12,281
Closed -$66.9K
ECVT icon
769
Ecovyst
ECVT
$1.35B
– –
-11,580
Closed -$101K
ED icon
770
Consolidated Edison
ED
$41.3B
– –
-3,609
Closed -$363K
ELP
771
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
– –
-14,343
Closed -$141K
ENPH icon
772
Enphase Energy
ENPH
$4.79B
– –
-9,287
Closed -$329K
ENTA icon
773
Enanta Pharmaceuticals
ENTA
$367M
– –
-35,846
Closed -$429K
ENVA icon
774
Enova International
ENVA
$6.2B
– –
-2,452
Closed -$282K
EPAC icon
775
Enerpac Tool Group
EPAC
$1.9B
– –
-5,407
Closed -$222K
29 30
31
32 33

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.